v3.26.1
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues        
Premiums $ 9,859 $ 9,156 $ 19,671 $ 21,892
Net investment income 272 236 474 474
TOTAL REVENUES 71,668 67,178 140,162 132,680
Benefits and expenses        
Pharmacy and other service costs 56,703 53,268 110,803 101,666
Medical costs and other benefit expenses 8,430 7,749 16,354 18,247
Selling, general and administrative expenses 3,470 3,433 7,192 7,646
Amortization of acquired intangible assets 389 422 779 844
TOTAL BENEFITS AND EXPENSES 68,992 64,872 135,128 128,403
Income from operations 2,676 2,306 5,034 4,277
Interest expense and other (356) (337) (713) (699)
Gain on sale of businesses 6 0 17 41
Net investment (losses) gains (69) 52 189 50
Income before income taxes 2,257 2,021 4,527 3,669
TOTAL INCOME TAXES 382 389 791 628
Net income 1,875 1,632 3,736 3,041
Less: Net income attributable to noncontrolling interests 215 100 422 186
SHAREHOLDERS' NET INCOME $ 1,660 $ 1,532 $ 3,314 $ 2,855
Shareholders' net income per share        
Basic (in dollars per share) $ 6.31 $ 5.76 $ 12.61 $ 10.63
Diluted (in dollars per share) $ 6.29 $ 5.71 $ 12.55 $ 10.55
Pharmacy revenues        
Revenues        
Revenue from contract with customer $ 57,172 $ 53,649 $ 111,209 $ 102,282
Fees and other revenues        
Revenues        
Revenue from contract with customer $ 4,365 $ 4,137 $ 8,808 $ 8,032